$USD
$USD
home / United States / Pliant Therapeutics
Pliant Therapeutics logo

Pliant Therapeutics Market Cap

$0.66 B
-9.13 M
NASDAQ:PLRX · January 22, 2025
Share price
$10.92
Enterprise Value
$0.33 B
Change (1-Year)
-35.7%
Global Rank
#5761
Country Rank
#2187
Regions
USA
Market cap

As of January 22, 2025, Pliant Therapeutics (PLRX) has a market cap of $0.66 billion USD. According to our data, Pliant Therapeutics is ranked No.5761 in global market value.

Sector Rank:
PLRX Market Capitalization Growth
30D Growth:
-16.9%
1 Years Growth:
-35.7%
3 Years Growth:
-1.6%
5 Years Growth:
-47.4%
Total Growth:
-47%

Pliant Therapeutics Market Cap Chart

1M
3M
6M
YTD
1Y
3Y
5Y
10Y
15Y
20Y
MAX

Pliant Therapeutics Market Cap CAGR Chart

Pliant Therapeutics Market Cap History 2020 - 2025

Year Market Cap %Change
Jan 22, 2025 $0.66 B
-17.08%
Dec 31, 2024 $0.80 B
-27.28%
Dec 29, 2023 $1.10 B
-6.31%
Dec 30, 2022 $1.18 B
43.19%
Dec 31, 2021 $0.82 B
-40.58%
Dec 31, 2020 $1.38 B
100%

Similar Companies to Pliant Therapeutics

Name Market Cap Market cap difference Regions
FibroGen Logo
FibroGen
FGEN
$50.79 M
0.000 M
USA icon
USA
Galapagos NV Logo
Galapagos NV
GLPG
$1.58 B
0.000 M
Belgium icon
Belgium
Genfit Logo
Genfit
GNFT
$0.18 B
-0.000 M
France icon
France
Morphic Therapeutic Logo
Morphic Therapeutic
MORF
$2.86 B
0.000 M
USA icon
USA
Akero Therapeutics Logo
Akero Therapeutics
AKRO
$1.75 B
0.000 M
USA icon
USA
Gilead Sciences Logo
Gilead Sciences
GILD
$115.95 B
0.002 M
USA icon
USA
Bristol-Myers Squibb Logo
Bristol-Myers Squibb
BMY
$115.77 B
0.000 M
USA icon
USA

About Pliant Therapeutics Inc.

Name
Pliant Therapeutics, Inc.
Headquarters
South San Francisco,CA
symbol
PLRX
CURRENCY
USD
country
United States
fullTimeEmployees
166
exchange
NMS
firstTradeDateEpochUtc
2020/06/03
PLRX Market Cap Formula
Market Cap = PLRX Stock Price * PLRX Shares Outstanding
= $10.92 * 60.85 M
= $0.66 B
What is Market Cap?
Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.
Material